Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Züger

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 28, 2018
Thomas Züger, Lia Bally, Markus Laimer, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 2, 2026
The power of lifestyle intervention to induce glycaemic control in a patient with newly diagnosed type 2 diabetes and HbA1c >10Antonio Ferreira, Thomas Züger, Marc Y Donath, et al.
Swiss Medical Weekly|April 5, 2024
Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centreVera Lehmann, Franco Noti, Markus Laimer, et al.
Obesity Surgery|February 9, 2023
Weight Loss After Bariatric Surgery in Different Age GroupsUrs Pfefferkorn, Sabrina Hort, Melika Beluli, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory studyJuri Künzler, Thomas Züger, Christoph Stettler, et al.
Journal of Diabetes Science and Technology|June 14, 2013
An early warning system for hypoglycemic/hyperglycemic events based on fusion of adaptive prediction modelsElena Daskalaki, Kirsten Nørgaard, Thomas Züger, et al.
Endocrinology, Diabetes & Metabolism|February 3, 2021
Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global surveySam N Scott, Federico Y Fontana, Thomas Züger, et al.
Diabetes, Obesity & Metabolism|June 12, 2019
Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)Andreas Melmer, Thomas Züger, Dana M Lewis, et al.
Plos One|October 22, 2025
GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trialMaria Carolina Fragozo-Ramos, Gabriela Schenker, Matthias Hepprich, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2024
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational StudyAnastas Kick, Khadija M'Rabet-Bensalah, Flavio Acquistapace, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutische Umschau. Revue Therapeutique|March 28, 2018
Thomas Züger, Lia Bally, Markus Laimer, et al.
Endocrinology, Diabetes & Metabolism Case Reports|April 2, 2026
The power of lifestyle intervention to induce glycaemic control in a patient with newly diagnosed type 2 diabetes and HbA1c >10Antonio Ferreira, Thomas Züger, Marc Y Donath, et al.
Swiss Medical Weekly|April 5, 2024
Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centreVera Lehmann, Franco Noti, Markus Laimer, et al.
Obesity Surgery|February 9, 2023
Weight Loss After Bariatric Surgery in Different Age GroupsUrs Pfefferkorn, Sabrina Hort, Melika Beluli, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory studyJuri Künzler, Thomas Züger, Christoph Stettler, et al.
Journal of Diabetes Science and Technology|June 14, 2013
An early warning system for hypoglycemic/hyperglycemic events based on fusion of adaptive prediction modelsElena Daskalaki, Kirsten Nørgaard, Thomas Züger, et al.
Endocrinology, Diabetes & Metabolism|February 3, 2021
Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global surveySam N Scott, Federico Y Fontana, Thomas Züger, et al.
Diabetes, Obesity & Metabolism|June 12, 2019
Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS)Andreas Melmer, Thomas Züger, Dana M Lewis, et al.
Plos One|October 22, 2025
GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trialMaria Carolina Fragozo-Ramos, Gabriela Schenker, Matthias Hepprich, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2024
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational StudyAnastas Kick, Khadija M'Rabet-Bensalah, Flavio Acquistapace, et al.
Pageof 2